Please assess the completion status of the following clinical trial:

Trial Title: Does Transcranial Magnetic Stimulation of the Cingulate Cortex Modulate the Perception of Dyspnoea?

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Refractory dyspnoea (persisting sensation of air hunger despite optimisation of medical treatment)~2. Histocytologically proven thoracic malignancy~3. Written informed consent~Exclusion Criteria:~1. Age \<18 years~2. Left-handed~3. Structural brain disease (including cerebral metastasis)~4. Personal or family history of seizures~5. Implantable metallic objects e.g. a pacemaker, or other contraindication to transcranial magnetic stimulation~6. Pregnant or breast feeding~7. Previous electroconvulsive therapy (ECT)~8. Poor mobility~9. Visual impairment~10. Lack of social support / home to go to after the study treatment~11. Alcohol dependency~12. PaCO2 \>6kPa at rest~13. Inability to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): Patients will be identified from the Oxford Pleural Clinic and from referrals within the multi-disciplinary team including palliative care and oncology services.~Screening criteria are based on normal practice and consecutive eligible patients will be offered trial entry. The principal investigator or a nominated member of staff will approach participants who fulfil the criteria for inclusion in the study. Screening logs will be kept.

Based on this trial design, predict the completion outcome and termination type (if applicable).